All In Biotech

Drug Trial Radar · NCT04880109

A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

A Phase 2, Double-blind, Placebo-controlled, Efficacy, and Safety Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

Last checked: Nov 20, 2026Latest source record: Jun 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

16

Actual

Start

Oct 20, 2021

Primary completion

Apr 28, 2022

Study completion Apr 28, 2022

Sponsor

Lead sponsor
Aptabio Therapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
Covance
First posted
May 10, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase 2 study is to assess the safety and tolerability of APX-115 active doses compared to placebo following multiple oral dosing in hospitalized patients with confirmed, mild to moderate, symptomatic COVID-19. It is anticipated that approximately 80 patients will be randomized into the study in a 1:1 ratio to 100 mg APX-115 or placebo arm.

Conditions

  • COVID-19

Interventions

  • APX-115Drug

    Oral administration of APX-115 100 mg capsule once daily for 14 days

  • PlaceboDrug

    Oral administration of placebo capsule once daily for 14 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse EventsTime frame: over the 60-day period

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • FASN, FAHA; John L. McClellan Memorial Veterans Hospital

    Little Rock, Arkansas

  • Anne Arundel Medical Center

    Annapolis, Maryland

  • MSc, FAAN; Metro Health Hospital - Professional Building

    Wyoming, Michigan

  • FCCP; Jamaica Hospital Medical Center

    Jamaica, New York

  • TriHealth Bethesda North Hospital

    Cincinnati, Ohio

  • Medical City Fort Worth

    Fort Worth, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.